Meta-analysis: impact of drug class on adherence to antihypertensives.
about
Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims data.Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.A multifaceted prospective memory intervention to improve medication adherence: design of a randomized control trial.Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults.Antihypertensive drug class and adherence: an electronic monitoring studyIncidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?Patterns and predictors of antihypertensive medication used 1 year after ischemic stroke or TIA in urban China.Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.Adherence to cardiovascular medications: lessons learned and future directions.Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis.The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.Improving adherence with medication: a selective literature review based on the example of hypertension treatment.Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.Angiotensin receptor blockers in clinical practice--implications of the ONTARGET study.Renin-angiotensin system blocking drugs.Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.Drug therapy for the patient with resistant hypertension.Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department.Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.Phase 4 Studies in Heart Failure - What is Done and What is Needed?Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence.A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management.How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).Influence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.Drug Side Effect Symptoms and Adherence to Antihypertensive Medication.Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting.Adherence to Treatment in Hypertension.Assessing the Multidimensional Relationship Between Medication Beliefs and Adherence in Older Adults With Hypertension Using Polynomial Regression.Implication of different initial beta blockers on treatment persistence: atenolol vs new-generation beta blocker, a population-based study.Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI Study
P2860
Q30701410-0FD94E4E-CA66-432C-A7B4-5EB68915119DQ34189897-838E8560-75DC-4C85-95AD-0671CDE5287EQ35532720-4F7E4415-7862-4DC5-BD85-7F4BD92597E3Q35563068-0330CCEB-3B9E-4292-A4A0-7B48AB3D89F5Q35661858-FFD37DD0-88BD-4525-8C17-D661B45CB0E8Q35684200-B4B3AC4C-B2D6-4E23-B377-575A90D4DF98Q35845400-445F46D4-9149-4022-A1C8-F1EF84C419E1Q36557245-5205F938-8A0C-429C-B6E8-09328A6970B0Q36713941-91F9D3BA-D248-40D7-B0C1-1ECC90388986Q36804187-532BC769-DDFD-4E18-8D5F-FB4B1D8C5EB5Q37328828-3BFF2C9B-5F8E-4C18-83D6-DCDD994C20DDQ37454789-69E4C00E-2E68-4D0D-84F5-8CFE7AC2E5E0Q37591809-3138A593-45F2-4EC4-90A1-1AA93A61C6CBQ37593511-58272753-7A99-4074-A6B9-CAC146CA461CQ37632055-E3DF6A70-9314-4D46-8ADA-C89BCB1B8ECCQ37973403-A9D1C3F1-A4A3-482C-BCB3-88A585D865F3Q37994859-D791A4B1-B50D-4A20-AE9D-42B8F20288E9Q38137851-1890681B-26CF-4BED-BB7B-1D904F5FD29DQ38180204-4A209BCF-7FB1-4F44-B56D-3F7B83E35CB1Q38373858-F2E01FB5-663E-460E-A9F2-33810B1E8B26Q38707976-F1085B3D-15AE-4011-BB15-512720FBB520Q38819507-148EB9C9-1418-446F-A80E-F17B867A31A8Q38859866-C2CC7A2B-13C9-464F-B5F3-5DB444401EA5Q39427698-E2860002-7597-4D6B-B22B-207019EAEA9CQ39505601-829ACBC6-A4D0-47FB-AF19-349D6299667BQ39584032-4D327D5F-C034-4C51-8819-910BE8D6B619Q39641845-8788881A-EFF3-48AE-A06A-C4B527F870ACQ39683030-411366F8-5D6D-4B05-801E-B934973CB8F3Q39877267-6451B556-3FE2-4ABE-97FE-ACFF00C91E47Q40236116-2C93BA53-41D8-43BE-A9E3-624CEAFC7179Q48029889-84CA5F1A-42BF-4C60-B225-CDAA8AB94D71Q48967636-97F087D7-3E78-4A26-B5E2-74CCA0D9BD50Q52655908-F44D7E6D-8B33-4235-8FB4-2BBF68901721Q53094165-D524AD3E-4C23-4749-A50B-416FE8D765F8Q53676374-93CAB147-FDF6-46E0-8D55-5428BE048916Q57491583-07D384A9-0CB0-4A42-AE88-F322BD8AAFF3
P2860
Meta-analysis: impact of drug class on adherence to antihypertensives.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Meta-analysis: impact of drug class on adherence to antihypertensives.
@ast
Meta-analysis: impact of drug class on adherence to antihypertensives.
@en
Meta-analysis: impact of drug class on adherence to antihypertensives.
@nl
type
label
Meta-analysis: impact of drug class on adherence to antihypertensives.
@ast
Meta-analysis: impact of drug class on adherence to antihypertensives.
@en
Meta-analysis: impact of drug class on adherence to antihypertensives.
@nl
prefLabel
Meta-analysis: impact of drug class on adherence to antihypertensives.
@ast
Meta-analysis: impact of drug class on adherence to antihypertensives.
@en
Meta-analysis: impact of drug class on adherence to antihypertensives.
@nl
P2860
P50
P1433
P1476
Meta-analysis: impact of drug class on adherence to antihypertensives.
@en
P2093
Mark Woodward
Ziad Sergie
P2860
P304
P356
10.1161/CIRCULATIONAHA.110.983874
P407
P577
2011-04-04T00:00:00Z